title: Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials Group.
authors.affiliation: University of California, San Diego, La Jolla, USA.
authors.forename: S A
authors.initials: SA
authors.lastname: Spector
authors.forename: S
authors.initials: S
authors.lastname: Blanchard
authors.forename: D W
authors.initials: DW
authors.lastname: Wara
authors.forename: J M
authors.initials: JM
authors.lastname: Oleske
authors.forename: K
authors.initials: K
authors.lastname: McIntosh
authors.forename: D
authors.initials: D
authors.lastname: Hodes
authors.forename: W M
authors.initials: WM
authors.lastname: Dankner
authors.forename: M
authors.initials: M
authors.lastname: Salgo
authors.forename: J
authors.initials: J
authors.lastname: McNamara
mesh_terms: D000293:Adolescent; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D016655:HIV Core Protein p24 / Q000097:blood; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D016047:Zalcitabine / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D016655:HIV Core Protein p24; D015215:Zidovudine; D016047:Zalcitabine